Open Orphan chief to underwrite part of £30m hVivo takeover

Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm

15th December, 2019
Open Orphan chief to underwrite part of £30m hVivo takeover
Open Orphan chief executive Cathal Friel: his underwriting will only kick in if the company fails to raise the cash from external investors

Open Orphan chief executive Cathal Friel will underwrite about €3 million of the company’s planned fundraising as part of its £30 million takeover of British company hVivo.

Pharma services company Open Orphan is to launch a share placing early in the new year to raise as much as £10 million from investors to fund the takeover of the British company, which is involved in clinical trials. Friel is one of the largest investors...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Chanelle founder invests €100k in Redesdale Group

Malin shareholders in line for windfall after €119 million cash boost

Amryt seeks to have rare condition drug approved for payment

Icon to restore staff pay as business recovers from virus